Shares of medical equipment maker Thermo Fisher TMO.N rise 1.7% to $436.89 premarket
TMO posts Q2 adj. profit of $5.36 per share, beating analysts' estimate of $5.22 per share - data compiled by LSEG
Company reports Q2 revenue of $10.85 billion vs estimates of $10.68 billion
Sales at the company's laboratory products segment, which makes up more than half of its total sales, came in at $5.99 billion vs estimate of $5.79 billion
Up to last close, stock down 17.8% YTD